Target Market

Total Addressable Market (TAM)
    – 530 million adults globally at risk of diabetes

Serviceable Addressable Market (SAM)
    – 96 million adults in the U.S. with prediabetes

Serviceable Obtainable Market (SOM)
    – Targeting 0.5% of the U.S. market initially
    – Approximately 480,000 individuals

Competitor Overview

Direct Competitors:
    – No direct competitors currently targeting prediabetes monitoring.

Indirect Competitors:
Dexcom & Abbott:
    – Focus on glucose monitoring for type 2 diabetes patients.
    – Invasive methods requiring blood samples.
Traditional Diagnostic Labs:
    – Fasting, blood draws, and clinic visits required.

Financial Picture

We aim to raise $75,000 over the next 12 months through a diversified funding strategy. This includes grants, owner contributions, and investor funding to support R&D, prototyping, and commercialization milestones

Scroll to Top